Pregnancy vaccine reduces baby hospital admissions for RSV by 80%

• Maternal RSV vaccination reduces infant hospitalisation risk by 80%, offering significant protection against severe lower respiratory tract infection in the first months of life
• The vaccine demonstrates excellent safety and efficacy profile, making it a valuable tool for preventing serious RSV disease in vulnerable neonates
• Consider offering RSV vaccination to pregnant women as part of routine antenatal care to protect newborns during their highest-risk period for severe infection

A study confirms the vaccine gives excellent protection for babies against life-threatening chest infections.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.